Discovery of systematic responses and potential biomarkers induced by ochratoxin A using metabolomics

References

• Baudrimont I, Betbeder A-M, Gharbi A, Pfohl-Leszkowicz A, Dirheimer G, Creppy E. 1994. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology. 89:101–111.
   PubMed Web of Science ®Google Scholar
• Beger RD, Sun J, Schnackenberg LK. 2010. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol. 243:154–166.
   PubMed Web of Science ®Google Scholar
• Bendele AM, Carlton WW, Krogh P, Lillehoj E. 1985. Ochratoxin A carcinogenesis in the (C57BL/6J× C3H) F1 mouse. J Natl Cancer Inst. 75:733–742.
   PubMed Web of Science ®Google Scholar
• Boorman GA, Mcdonald MR, Imoto S, Persing R. 1992. Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol Pathol. 20:236–245.
   PubMed Web of Science ®Google Scholar
• Boudonck KJ, Mitchell MW, Nemet L, Keresztes L, Nyska A, Shinar D, Rosenstock M. 2009. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol. 37:280–292.
   PubMed Web of Science ®Google Scholar
• Dai Q, Zhao J, Qi X, Xu W, He X, Guo M, Dweep H, Cheng W-H, Luo Y, Xia K, et al. 2014. MicroRNA profiling of rats with ochratoxin A nephrotoxicity. BMC Genomics. 15:333.
   PubMed Web of Science ®Google Scholar
• de Groene EM, Jahn A, Horbach GJ, Fink-Gremmels J. 1996. Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. Environ Toxicol Pharmacol. 1:21–26.
   PubMed Web of Science ®Google Scholar
• Duarte S, Lino C, Pena A. 2010a. Mycotoxin food and feed regulation and the specific case of ochratoxin A: a review of the worldwide status. Food Addit Contam: Part A. 27:1440–1450.
   Web of Science ®Google Scholar
• Duarte S, Pena A, Lino C. 2010b. A review on ochratoxin A occurrence and effects of processing of cereal and cereal derived food products. Food Microbiol. 27:187–198.
   PubMed Web of Science ®Google Scholar
• Dunn WB, Broadhurst DI, Deepak SM, Buch MH, McDowell G, Spasic I, Ellis DI, Brooks N, Kell DB, Neyses L. 2007. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics. 3:413–426.
   Web of Science ®Google Scholar
• Guo M, Huang K, Chen S, Qi X, He X, Cheng W-H, Luo Y, Xia K, Xu W. 2014. Combination of metagenomics and culture-based methods to study the interaction between Ochratoxin A and Gut Microbiota. Toxicol Sci. doi:10.1093/toxsci/kfu128.
   Google Scholar
• Huang Q, Tan Y, Yin P, Ye G, Gao P, Lu X, Wang H, Xu G. 2013. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 73:4992–5002.
   PubMed Web of Science ®Google Scholar
• Jennings P, Weiland C, Limonciel A, Bloch KM, Radford R, Aschauer L, McMorrow T, Wilmes A, Pfaller W, Ahr HJ, et al. 2012. Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model. Arch Toxicol. 86:571–589.
   PubMed Web of Science ®Google Scholar
• Jia L, Chen J, Yin P, Lu X, Xu G. 2008. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics. 4:183–189.
   Web of Science ®Google Scholar
• Lea T, Steien K, Størmer FC. 1989. Mechanism of ochratoxin A-induced immunosuppression. Mycopathologia. 107:153–159.
   PubMed Web of Science ®Google Scholar
• Mally A. 2012. Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Toxicol Sci. 127:315–330.
   PubMed Web of Science ®Google Scholar
• Mantle PG, Nicholls AW, Shockcor JP. 2011. 1H NMR spectroscopy-based metabolomic assessment of uremic toxicity, with toxicological outcomes, in male rats following an acute, mid-life insult from ochratoxin A. Toxins. 3:504–519.
   PubMedGoogle Scholar
• Mayura K, Stein AF, Berndt WO, Phillips TD. 1984. Teratogenic effects of ochratoxin A in rats with impaired renal function. Toxicology. 32:277–285.
   PubMed Web of Science ®Google Scholar
• NTP. 1989. Toxicology and carcinogenesis studies of ochratoxin A (CAS No.303-47-9) in F344/N rats(gavage studies). Natl Toxicol Program Tech Rep. 1–142.
   Google Scholar
• Omar RF, Gelboin HV, Rahimtula AD. 1996. Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin A. Biochem Pharmacol. 51:207–216.
   PubMed Web of Science ®Google Scholar
• Palma N, Cinelli S, Sapora O, Wilson SH, Dogliotti E. 2007. Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem Res Toxicol. 20:1031–1037.
   PubMed Web of Science ®Google Scholar
• Pfohl‐Leszkowicz A, Manderville RA. 2007. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nut Food Res. 51:61–99.
   PubMed Web of Science ®Google Scholar
• Qi X, Yang X, Chen S, He X, Dweep H, Guo M, Cheng W-H, Xu W, Luo Y, Gretz N. 2014. Ochratoxin A induced early hepatotoxicity: new mechanistic insights from microRNA, mRNA and proteomic profiling studies. Scientific Reports.
   Google Scholar
• Rached E, Hard GC, Blumbach K, Weber K, Draheim R, Lutz WK, Ozden S, Steger U, Dekant W, Mally A. 2007. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/N rats. Toxicol Sci. 97:288–298.
   PubMed Web of Science ®Google Scholar
• Ringot D, Chango A, Schneider YJ, Larondelle Y. 2006. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem Biol Interact. 159:18–46.
   PubMed Web of Science ®Google Scholar
• Schaaf G, Nijmeijer S, Maas R, Roestenberg P, De Groene E, Fink-Gremmels J. 2002. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1588:149–158.
   PubMed Web of Science ®Google Scholar
• Shen XL, Zhang Y, Xu W, Liang R, Zheng J, Luo Y, Wang Y, Huang K. 2012. An iTRAQ-based mitoproteomics approach for profiling the nephrotoxicity mechanisms of ochratoxin A in HEK 293 cells. J Proteom. 78:398–415.
   PubMed Web of Science ®Google Scholar
• Shlosberg A, Elkin N, Malkinson M, Orgad U, Hanji V, Bogin E, Weisman Y, Meroz M, Bock R. 1997. Severe hepatopathy in geese and broilers associated with ochratoxin in their feed. Mycopathologia. 138:71–76.
   PubMed Web of Science ®Google Scholar
• Sieber M, Wagner S, Rached E, Amberg A, Mally A, Dekant W. 2009. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery. Chem Res Toxicol. 22:1221–1231.
   PubMed Web of Science ®Google Scholar
• Smith JL, Wishnok JS, Deen WM. 1994. Metabolism and excretion of methylamines in rats. Toxicol Appl Pharmacol. 125:296–308.
   PubMed Web of Science ®Google Scholar
• Stoev S, Stoeva J, Anguelov G, Hald B, Creppy E, Radic B. 1998. Haematological, biochemical and toxicological investigations in spontaneous cases with different frequency of porcine nephropathy in Bulgaria. J Vet Med Ser A. 45:229–236.
   Google Scholar
• Turesky RJ. 2005. Perspective: ochratoxin A is not a genotoxic carcinogen. Chem Res Toxicol. 18:1082–1090.
   PubMed Web of Science ®Google Scholar
• Wang H, Bai J, Chen G, Li W, Xiang R, Su G, Pei Y. 2013. A metabolic profiling analysis of the acute hepatotoxicity and nephrotoxicity of Zhusha Anshen Wan compared with cinnabar in rats using 1H NMR spectroscopy. J Ethnopharmacol. 146:572–580.
   PubMed Web of Science ®Google Scholar
• Waters NJ, Waterfield CJ, Farrant RD, Holmes E, Nicholson JK. 2005. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato-and nephrotoxicity. Chem Res Toxicol. 18:639–654.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ye Y, An Y, Tian Y, Wang Y, Tang H. 2010. Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices. J Proteome Res. 10:614–623.
   PubMed Web of Science ®Google Scholar